THE DEAL, AT A GLANCE
From the announcementOxford spin-out OMass Therapeutics
01Who is involvedBacked by Bain Capital Life Sciences, Forbion, Novo HoldingsFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedOxford spin-out OMass Therapeutics raised Series C, announced 2026-10-16From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Oxford spin-out OMass Therapeutics · Financing Record
Explore source-linked visual explanations for Oxford spin-out OMass Therapeutics. Unsupported claims are withheld while source review continues.
Record 14237 · Recorded date: 2026-10-16
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →